Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Barriers to the release of human tissue for clinical trials research in the UK: a national survey of cellular pathology laboratories on behalf of the National Cancer Research Institute's Cellular Molecular Pathology (CM-Path) initiative.
Macklin PS, Hall A, Lee J, Hair J, Speirs V, Thomas GJ, Oien KA, Verrill C. Macklin PS, et al. J Clin Pathol. 2019 Jan;72(1):52-57. doi: 10.1136/jclinpath-2018-205476. Epub 2018 Oct 1. J Clin Pathol. 2019. PMID: 30275096
Quality assurance guidance for scoring and reporting for pathologists and laboratories undertaking clinical trial work.
Robinson M, James J, Thomas G, West N, Jones L, Lee J, Oien K, Freeman A, Craig C, Sloan P, Elliot P, Cheang M, Rodriguez-Justo M, Verrill C; UK National Cancer Research Institute (NCRI) Cellular-Molecular Pathology (CM-Path) clinical trials working group. Robinson M, et al. Among authors: oien k. J Pathol Clin Res. 2019 Apr;5(2):91-99. doi: 10.1002/cjp2.121. Epub 2018 Nov 29. J Pathol Clin Res. 2019. PMID: 30407751 Free PMC article.
Training and accreditation standards for pathologists undertaking clinical trial work.
Rees G, Salto-Tellez M, Lee JL, Oien K, Verrill C, Freeman A, Mirabile I, West NP; National Cancer Research Institute (NCRI) Cellular-Molecular Pathology (CM-Path) clinical trials working group. Rees G, et al. Among authors: oien k. J Pathol Clin Res. 2019 Apr;5(2):100-107. doi: 10.1002/cjp2.124. Epub 2019 Feb 27. J Pathol Clin Res. 2019. PMID: 30680942 Free PMC article.
The use of digital pathology and image analysis in clinical trials.
Pell R, Oien K, Robinson M, Pitman H, Rajpoot N, Rittscher J, Snead D, Verrill C; UK National Cancer Research Institute (NCRI) Cellular-Molecular Pathology (CM-Path) quality assurance working group. Pell R, et al. Among authors: oien k. J Pathol Clin Res. 2019 Apr;5(2):81-90. doi: 10.1002/cjp2.127. Epub 2019 Mar 25. J Pathol Clin Res. 2019. PMID: 30767396 Free PMC article.
Pathology and regulation for research in the UK: an overview.
Driskell OJ, Lee JL, Oien KA, Hall A, Verrill C; CM-Path QA Panel. Driskell OJ, et al. F1000Res. 2019 Jun 27;8:975. doi: 10.12688/f1000research.19732.2. eCollection 2019. F1000Res. 2019. PMID: 31448108 Free PMC article.
164 results